Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis

Biochemical and Biophysical Research Communications

Volumn 319, Issue 2, 2004, Pages 562-568

  Ko, Samuel ^a   Chu, Kent Man ^a   Luk, John M ^a   Wong, Bonnie W ^a   Yuen, Siu Tsan ^a   Leung, Suet Yi ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gastric adenocarcinoma; LI cadherin; Lymph node metastasis; Tumor marker

Indexed keywords

CADHERIN; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE; LIVER; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH MUCOSA; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOTTING, WESTERN; CADHERINS; CARRIER PROTEINS; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 2642554613     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.197     Document Type: Article

References (29)

1. Boring C.C., Squires T.S., Tong T., Montgomery S. Cancer statistics. CA Cancer J. Clin. 44:1994;7-26
2. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 5:1993;806-811
3. Buxton R.S., Magee A.I. Structure and interactions of desmosomal and other cadherins. Semin. Cell Biol. 3:1992;157-167
4. Perl A.K., Wilgenbus P., Dahl U., Semb H., Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 392:1998;190-193
5. 2+-dependent cell adhesion molecule expressed in liver and intestine. J. Cell Biol. 125:1994;1353-1369
6. Angres B., Kim L., Jung R., Gessner R., Tauber R. LI-cadherin gene expression during mouse intestinal development. Dev. Dyn. 221:2001;182-193
7. Wong B.W., Luk J.M., Ng I.O., Hu M.Y., Liu K.D., Fan S.T. Identification of liver-intestine cadherin in hepatocellular carcinoma - a potential disease marker. Biochem. Biophys. Res. Commun. 311:2003;618-624
8. Kreft B., Berndorff D., Bottinger A., Finnemann S., Wedlich D., Hortsch M., Tauber R., Gessner R. LI-cadherin-mediated cell-cell adhesion does not require cytoplasmic interactions. J. Cell Biol. 136:1997;1109-1121
9. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 64:1965;31-39
10. Nishi M., Omori Y., Miwa K. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. first ed. 1995;Kanehara, Tokyo
11. Tahara H. Molecular biology of gastric cancer. World J. Surg. 19:1995;484-490
12. Leung S.Y., Yuen S.T., Chung L.P., Chu K.M., Chan A.S., Ho J.C. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinoma with high-frequency microsatellite instability. Cancer Res. 9:1999;159-164
13. Huiping C., Kristjansdottir S., Bergthorsson J.T., Jonasson J.G., Magnusson J., Egilsson V., Ingvarsson S. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. Eur. J. Cancer. 38:2002;728-735
14. Leung S.Y., Chau K.Y., Yuen S.T., Chu K.M., Branicki F.J., Chung L.P. p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma. Histopathology. 33:1998;311-317
15. Kabashima A., Maehara Y., Kakeji Y., Sugimachi K. Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology. 60:2001;146-150
16. Joo Y.E., Rew J.S., Choi S.K., Bom H.S., Park C.S., Kim S.J. Expression of E-cadherin and catenins in early gastric cancer. J. Clin. Gastroenterol. 35:2002;35-42
17. v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J. 12:1993;307-314
18. Gessner R., Tauber R. Intestinal cell adhesion molecules. Liver-intestine cadherin. Ann. N. Y. Acad. Sci. 915:2000;136-143
19. Grotzinger C., Kneifel J., Patschan D., Schnoy N., Anagnostopoulos I., Faiss S., Tauber R., Wiedenmann B., Gessner R. LI-cadherin: a marker of gastric metaplasia and neoplasia. Gut. 49:2001;73-81
20. Hinoi T., Lucas P.C., Kuick R., Hanash S., Cho K.R., Fearon E.R. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestine metaplasia. Gastroenterology. 123:2002;1565-1577
21. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J. Clin. Oncol. 15:1997;826-832
22. Etoh T., Inoue H., Tanaka S., Barnard G.F., Kitano S., Mori M. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res. 61:2001;2145-2153
23. Carmeliet P., Lampugnani M., Moons L., Breviario F., Compemolle V., Bono F., Balconi G., Spagnuolo R., Oostuyse B., Dewerchin M., Zanetti A., Angellilo A., Mattot V., Nuyens D., Lutgens E., Clotman F., de Ruiter M.C., Gittenberger-de Groot A., Poelmann R., Lupu F., Herbert J.M., Collen D., Dejana E. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 98:1999;147-157
24. Behrens J., von Kries J.P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642
25. Shibamoto S., Hayakawa M., Takeuchi K., Hori T., Oku N., Miyazawa K., Kitamura N., Takeichi M., Ito F. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes. Commun. 205:1994;73-78
26. Gaspar M.J., Arribas I., Coca M.C., Diez-Alonso M. Prognostic value of carcinoembryonic antigen, CA19-9 and CA72-4 in gastric carcinoma. Tumour Biol. 22:2001;318-322
27. Chan A.O., Lam S.K., Chu K.M., Lam C.M., Kwok E., Leung S.Y., Yuen S.T., Law S.Y., Hui W.M., Lai K.C., Wong C.Y., Hu H.C., Lai C.L., Wong J. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut. 48:2001;808-811
28. Steele R.J., Lane D.P. Gene therapy for gastric cancer: problems and prospects. Surg. Oncol. 9:2000;13-16
29. Milligan J., Matteucci M., Martin J. Current concepts in antisense drug design. J. Med. Chem. 36:1993;1923-1937